BWI: Taro Transition Report For The Three Months Ended March 2012 on Form 20-F Available

Press release from Business Wire India
Source: Business Wire
Friday, June 29, 2012 09:49 AM IST (04:19 AM GMT)
Editors: General: Consumer interest; Business: Healthcare, biotechnology & pharmaceutical; Healthcare
--------------------------------------------------
(BW)(NY-TARO-PHARMACEUTICAL)(TARO)Taro Transition Report For The Three Months Ended March 2012 on Form 20-F Available


Hawthorne, New York, United States, Friday, June 29, 2012 -- (Business Wire India) --

Taro Pharmaceutical Industries Ltd. (NYSE: TARO, "Taro") announced that its Transition Report for the three month period ended March 31, 2012 on Form 20-F, filed with the Securities and Exchange Commission (the "SEC") today, is available within the Investor Relations section of Taro's website at www.taro.com. Hard copies of the report may be ordered free of charge by sending requests to Taro Pharmaceuticals U.S.A., Inc., Three Skyline Drive, Hawthorne, NY 10532, attention: William J. Coote or via email to William.Coote@Taro.com.

Additionally, the report may be accessed on the SEC's website at www.sec.gov.

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit Taro's website at www.taro.com.

CONTACT DETAILS
CONTACTS :

Taro Pharmaceutical Industries Ltd.
William J. Coote, 914-345-9001
VP, Treasurer
William.Coote@Taro.com


KEYWORDS
CONSUMER, HEALTHCARE, HEALTHCARE

If you wish to change your Business Wire India selection please click on this link http://www.businesswireindia.com/media/news.asp and use your personal username and password to login.

http://www.businesswire.com

Submit your press release at http://www.businesswireindia.com